Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...

Contracting ailments such as heart disease and diabetes before reaching 55 could heighten the likelihood of developing dementia later in life, according to fresh research. Strokes or the emergence of ...

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

The Alzheimer's Association of Greater Kentucky and Southern Indiana held the kickoff party on Wednesday for its Walk to End ...

The Broward Sheriff’s Office Missing Persons unit asked for the public’s help Wednesday in locating a 76-year-old man who ...

Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.

Single-cell genomics has unlocked new frontiers in understanding cell types in the brain and targeting them with therapies.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...